In an era defined by relentless professional demands and the blurring of boundaries between work and personal life, chronic fatigue…
Read More
Environmental Control of Superconductivity in Twisted Bilayer Graphene Opens New Frontiers for Quantum Electronics
A collaborative team of international researchers, led by physicists at The Ohio State University, has demonstrated a groundbreaking method for…
Read More
The Dawn of Psychedelics in Medicine: Navigating the Path to Safe and Effective Implementation
The landscape of mental healthcare is on the cusp of a significant transformation with the burgeoning approval of psychedelic-assisted therapies.…
Read More
Science News: A Century of Empowering Public Understanding of Science, Medicine, and Technology
Founded in 1921 with a steadfast commitment to delivering accurate and accessible information on the forefront of scientific discovery, Science…
Read More
Brazilian Tree Compounds Show Potent Multi-Target Activity Against COVID-19 Virus
Researchers have identified a group of natural compounds from a Brazilian tree that show promising activity against the virus responsible…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
In a recent clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello of This Week in Virology (TWiV), expressed significant concern…
Read More
Decoding the Inflammatory Landscape of the Bone Marrow Niche and Its Role in the Pathogenesis of Myeloid Malignancies
The human bone marrow functions as a biological engine of immense proportions, generating millions of new blood and immune cells…
Read More
Top Pharma Companies Set Sustainability Goals, But Emissions Are Still Increasing
The healthcare industry, a cornerstone of global well-being, paradoxically contributes an estimated 4.4% of total global emissions annually, placing it…
Read More
Scientists Stabilize Elusive Transitional State of Matter Using Nanoparticle Superlattices for Quantum Advancements
In a landmark achievement for the fields of nanotechnology and condensed matter physics, a collaborative team of researchers from Brown…
Read More
Sanofi’s Venglustat Receives Priority Review from US FDA for Type 3 Gaucher Disease
Sanofi has secured a significant milestone in its development of venglustat, an innovative oral glucosylceramide synthase inhibitor (GCSi), with the…
Read MoreYOU MAY HAVE MISSED
